Quality of life in head and neck cancer patients.
In recent years the number of Quality of Life (QOL) studies has increased rapidly. When evaluating outcomes of clinical trials in patients, one should take into consideration QOL aspects in addition to the well-known standard biomedical endpoints. The difficult question is how to select the best instrument from the flood of papers. A review and a few reflections are presented.